CN1788754A - Oral medicine for treating hyperosteogeny-pellet for treating bone pain - Google Patents
Oral medicine for treating hyperosteogeny-pellet for treating bone pain Download PDFInfo
- Publication number
- CN1788754A CN1788754A CN 200410064599 CN200410064599A CN1788754A CN 1788754 A CN1788754 A CN 1788754A CN 200410064599 CN200410064599 CN 200410064599 CN 200410064599 A CN200410064599 A CN 200410064599A CN 1788754 A CN1788754 A CN 1788754A
- Authority
- CN
- China
- Prior art keywords
- radix
- hyperosteogeny
- treating
- pellet
- oral medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to one kind of oral medicine for treating hyperosteogeny named as Gutongdan pill. The medicine is prepared with prepared rhizome of rehmannia 10-30 weight portions, epimedium 5-20 weight portions, angelica 10-30 weight portions clematis root 5-15 weight portions. The present invention has the functions of expelling wind evil, dispersing cold and eliminating wetness. Based on the theory of 'the kidney is in charge of bones and the liver is in charge of tendons', the present invention has increased liver and kidney benefiting medicine components for treating the primary causes, so that it has obviously raised curative effect on hyperosteogeny.
Description
Hyperosteogeny is a kind of chronic progressive external osteoarthritis of serious harm middle-aged and elderly people health, studies according to postmortem: the people was since 20 years old, and just there is degenerative change in the joint; During by 40 years old, almost 90% the people joint of bearing a heavy burden all has hypertrophy more or less to change.Though primary disease threatens patient's life unlike tumor, disability rate is also so high unlike rheumatoid arthritis, ankylosing spondylitis, but because of the prevalence height, long-term discomfort and dysfunction can not be underestimated the influence of patient quality of life due to it, step into aging society and old people's rapid increase along with China, the number of the infected of hyperosteogeny will rise thereupon, at present, left and right sides crowd had 25% people to suffer from this disease approximately in 50 years old, people Ze Da 50% about 60 years old, people about 70 years old reaches 100%, and the people's health in serious threat.Therefore, how to improve the curative effect of primary disease, reduce patient's misery and disability rate, become the focus of domestic and international research.Chinese patent application has been announced a kind of " hyperosteogeny is taken Chinese patent medicine orally " number No. 03135341, it is made up of Herba Epimedii, Radix Rehmanniae Preparata, Herba Cistanches, Huaihe River Fructus Psoraleae, Fructus Lycii, Caulis Spatholobi, Radix Salviae Miltiorrhizae, Cornu Cervi tablet, Rhizoma Cibotii, the Cortex Eucommiae, Radix Polygoni Multiflori, is used for treating hyperosteogeny.
Summary of the invention
Purpose of the present invention provides a kind of oral medicine for the treatment of hyperosteogeny---pellet for treating bone pain.
The present invention is achieved through the following technical solutions:
1, make by following components by weight portion:
Radix Rehmanniae Preparata (10-30) part, Herba Epimedii (5-20) part, Radix Angelicae Sinensis (10-30) part, Radix Aconiti Preparata (3-12) part and Radix Clematidis (5-15) part.
2, make by the optimum ratio of following ratio of weight and number:
Radix Rehmanniae Preparata (15-25) part, Herba Epimedii (5-15) part, Radix Angelicae Sinensis (12-20) part, Radix Aconiti Preparata (3-10) part and Radix Clematidis (6-12) part.
3, make by the proportioning component of following the best:
10 parts of 30 parts of Radix Rehmanniae Preparata, 20 parts of Herba Epimedii, 12 parts of Radix Angelicae Sinensis, 6 parts of Radix Aconiti Preparatas and Radix Clematidis.
Solution of the present invention is based on understanding and the Therapeutic Principle of motherland's medical science to " rheumatism involving the bone ", wet by invigorating the liver and kidney, strengthening bone and muscle, blood circulation promoting and blood stasis dispelling, removing cold and wind with reference to the modern pharmacology achievement in research, treats hyperosteogeny.According to theory of Chinese medical science, hyperosteogeny belongs to the category of the traditional Chinese medical science " rheumatism involving the bone ".Deficiency of the liver and kindey, essence and blood loss are the basic reasons that bone matrix hyperplasia takes place.The people is to person in middle and old age, the Liver and kidney degradation, and the essence and blood loss, suffering from a deficiency of the kidney is difficult bone strengthening, and deficiency of the liver is difficult nourishing muscle and tendon, and the not hard then vertebra of bone bone growth promoting thorn, muscle are not supported then laxity of ligament, and wind-cold damp pathogen is taken advantage of a weak point, and it is not smooth to cause QI-blood circulation, " stagnation of QI and blood may bring about pain ", and primary disease takes place.Radix Rehmanniae Preparata, Herba Epimedii, Radix Angelicae Sinensis in the side, liver and kidney tonifying negative and positive essence and blood improves body resistance against diseases, makes and just wins heresy, to effect a permanent cure; Radix Aconiti Preparata, Radix Clematidis are dispeled wind, cold, damp, the meridian dredging, and stopping numbness pain is to take stopgap measures.Each component combination, energy invigorating the liver and kidney, strengthening bone and muscle, the exopathogen of dispelling, the meridian dredging, it is suitable that QI and blood is transferred, and arthralgia pain is from removing.
Advantage of the present invention is that the effect of treatment hyperosteogeny is obvious.Reason is that the present invention is on the basis of traditional Chinese medical science tradition method of treatment " dispel the wind, cold expelling, dehumidifying ", according to the theory of " kidney governing bones ", " liver governing tendons ", has increased the weight of the medicine of liver and kidney tonifying negative and positive essence and blood with " effecting a permanent cure ", and curative effect is obviously improved.
For showing the curative effect of Chinese medicine of the present invention, through the external service department of Provincial Medicine Research Institute, Hebei traditional Chinese medical science osteopathia treatment bone matrix hyperplasia 62 examples, knee joint hyperosteogeny 15 examples wherein, cervical vertebra hyperosteogeny 26 examples, joint of lumbar vertebra hyperosteogeny 21 examples.Treat after 1 month clinical cure 30 examples, 12 examples that significantly take a turn for the better, 17 examples that take a turn for the better, invalid 3 examples.Total effective rate is 95.2%.
Embodiments of the present invention are as follows:
| Component | Implement 1 | Implement 2 | Implement 3 | Implement 4 | Implement 5 | Implement 6 | Implement 7 |
| Radix Rehmanniae Preparata | 10g | 20g | 30g | 15g | 20g | 25g | 30g |
| Herba Epimedii | 20g | 12g | 5g | 15g | 10g | 5g | 20g |
| Radix Angelicae Sinensis | 10g | 20g | 30g | 20g | 16g | 12g | 12g |
| Radix Aconiti Preparata | 12g | 9g | 3g | 3g | 7g | 10g | 6g |
| Radix Clematidis | 5g | 10g | 15g | 12g | 9g | 6g | 10g |
The production method that above-mentioned each component is made Chinese medicine of the present invention is:
Get Radix Rehmanniae Preparata, Herba Epimedii, Radix Angelicae Sinensis, Radix Aconiti Preparata, Radix Clematidis, mix, be soaked in water 2-4 hour, extract 3 times with the decocting extraction method, each time all used slow fire boiling 1-2 hour, with 3 decocting liquid mixing, concentrated, dry, promptly obtains finished product.
Utilize respectively component of the present invention, make said any oral medicine dosage form on the pharmaceutics of Chinese drugs, all can play same effect.
Claims (3)
1, a kind of oral medicine for the treatment of hyperosteogeny---pellet for treating bone pain is characterized in that it is made by following components by weight portion: Radix Rehmanniae Preparata (10-30) part, Herba Epimedii (5-20) part, Radix Angelicae Sinensis (10-30) part, Radix Aconiti Preparata (3-12) part and Radix Clematidis (5-15) part.
2, a kind of oral medicine for the treatment of hyperosteogeny according to claim 1---pellet for treating bone pain is characterized in that it is made by the optimum ratio of following ratio of weight and number: Radix Rehmanniae Preparata (15-25) part, Herba Epimedii (5-15) part, Radix Angelicae Sinensis (12-20) part, Radix Aconiti Preparata (3-10) part and Radix Clematidis (6-12) part.
3, a kind of oral medicine for the treatment of hyperosteogeny according to claim 1 and 2---pellet for treating bone pain is characterized in that it is made by the proportioning component of following the best: 10 parts of 30 parts of Radix Rehmanniae Preparata, 20 parts of Herba Epimedii, 12 parts of Radix Angelicae Sinensis, 6 parts of Radix Aconiti Preparatas and Radix Clematidis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410064599 CN1788754A (en) | 2004-12-13 | 2004-12-13 | Oral medicine for treating hyperosteogeny-pellet for treating bone pain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410064599 CN1788754A (en) | 2004-12-13 | 2004-12-13 | Oral medicine for treating hyperosteogeny-pellet for treating bone pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1788754A true CN1788754A (en) | 2006-06-21 |
Family
ID=36786998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410064599 Pending CN1788754A (en) | 2004-12-13 | 2004-12-13 | Oral medicine for treating hyperosteogeny-pellet for treating bone pain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1788754A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550380A (en) * | 2013-11-15 | 2014-02-05 | 王楚霄 | Traditional Chinese medicine composition for treating hyperostosis |
| CN105395754A (en) * | 2015-11-30 | 2016-03-16 | 马瑞 | Internal medicine for treating osteoproliferation |
| CN106511831A (en) * | 2016-12-06 | 2017-03-22 | 车念祖 | Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis |
| CN108888680A (en) * | 2018-09-26 | 2018-11-27 | 丁武沛 | A kind of Chinese medicine for treating liver-kidney yin deficiency osteoproliferation |
-
2004
- 2004-12-13 CN CN 200410064599 patent/CN1788754A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550380A (en) * | 2013-11-15 | 2014-02-05 | 王楚霄 | Traditional Chinese medicine composition for treating hyperostosis |
| CN103550380B (en) * | 2013-11-15 | 2015-07-08 | 王楚霄 | Traditional Chinese medicine composition for treating hyperostosis |
| CN105395754A (en) * | 2015-11-30 | 2016-03-16 | 马瑞 | Internal medicine for treating osteoproliferation |
| CN106511831A (en) * | 2016-12-06 | 2017-03-22 | 车念祖 | Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis |
| CN108888680A (en) * | 2018-09-26 | 2018-11-27 | 丁武沛 | A kind of Chinese medicine for treating liver-kidney yin deficiency osteoproliferation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1803187A (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
| CN102188668A (en) | Chinese medicinal preparation for lumbar vertebra osteoproliferation | |
| CN1876053A (en) | A pharmaceutical used for moxibustion and preparation method thereof | |
| CN102114230B (en) | Medicament for treating psoriasis | |
| CN101904969B (en) | Traditional Chinese medicine composition for treating proliferative diseases and preparation method thereof | |
| CN104258366A (en) | Traditional Chinese medicine preparation for lumbago and preparation method thereof | |
| CN103860675A (en) | Composition for treating rheumatoid arthritis | |
| CN101601767A (en) | A kind of Chinese medicine lotion for the treatment of calcaneodynia | |
| CN1788754A (en) | Oral medicine for treating hyperosteogeny-pellet for treating bone pain | |
| CN103611100A (en) | Traditional Chinese medicine for treating toothaches | |
| CN1322894C (en) | Chinese medicine for treating nipple discharge | |
| CN103330907B (en) | Hypothyroidism treatment traditional Chinese medicine composition | |
| CN101417114B (en) | Traditional Chinese medicine for treating hypertension and high blood-fat | |
| CN101380425B (en) | Arthrosis pill | |
| CN101530598B (en) | Plaster used for hyperosteogeny | |
| CN1903244A (en) | Traditional Chinese medicine composition for treating sexual disorders | |
| CN102552461A (en) | Medicinal moxa roll for treating knee osteoarthritis and preparation method thereof | |
| CN102302666A (en) | Health care medicinal liquor | |
| CN1698801A (en) | Capsule for treating hemiplegia and rheumatism | |
| CN100512837C (en) | Plaster for treating osteoarthropathy and preparing method | |
| CN1686431A (en) | A topical bath lotion for treating gout and its preparation method | |
| CN1454628A (en) | Chinese medicine decoction for curing fatty liver | |
| CN105998559A (en) | Traditional Chinese medicine composition for treating Parkinson's disease | |
| CN104383211A (en) | Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |